SCHAL-3

N/A

Report date: 2024/01/19 15:04:26
NME

Base Information

Drug NameSCHAL-3
Drug Alias NameSCHAL-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIon channels modulators
TargetsIon channels
Therapy Area/IndicationsPsoriasisKeratosis, Actinic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheriva Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheriva Biologics Inc
Active IndicationsN/A
Inactive IndicationsPsoriasisKeratosis, Actinic

Other Information

ATC CodeN/A
Related LinksN/A